Staying on top of the current research landscape with InCites Benchmarking & Analytics: An immuno-oncology case study

Size: px

Start display at page:

Download "Staying on top of the current research landscape with InCites Benchmarking & Analytics: An immuno-oncology case study"

Alexia Byrd
5 years ago
Views:

1 Staying on top of the current research landscape with InCites Benchmarking & Analytics: An immuno-oncology case study SLA Annual Conference Biomedical & Life Sciences Division Breakfast June 2017 Amy Braden, MSLIS

2 What is Clarivate Analytics? 2

3 What is immuno-oncology? 3

4 4 2,517 Number of organizations publishing research on I/O 85 Number of companies publishing research on I/O 466 Number of organizations funding research on I/O

5 5 2,517 Number of organizations publishing research on I/O 85 Number of companies publishing research on I/O 466 Number of organizations funding research on I/O

6 InCites & the Web of Science Core Collection 6

7 InCites & the Web of Science Core Collection 7

8 138% growth in Immuno-oncology (I/O) annual publications over the last 10 years Web of Science Core Collection Journal Articles 4, records , Source: Web of Science Core Collection

9 Timeline of I/O 9 Morrissey, K., Yuraszeck, T., Li, C.-C., Zhang, Y. and Kasichayanula, S. (2016), Immunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities. Clinical And Translational Science, 9: doi: /cts.12391

10 Who is doing high impact research in I/O? Top 10 publishing organizations by Category Normalized Citation Impact (CNCI) = average impact in field

Category Normalized Citation Impact 11 Business Law Substance Abuse Biology Oncology Respiratory System Agronomy times cited 1990 2015 Review Article Editorial Category Citation patterns differ by

11 Category Normalized Citation Impact 11 Business Law Substance Abuse Biology Oncology Respiratory System Agronomy times cited Review Article Editorial Category Citation patterns differ by subject category e.g. nanotechnology vs law Time Citations accumulate over time and at different rates depending on article age and category e.g. new articles may accumulate citations quickly, older ones more slowly or not at all Document Type Citations differ by document type within a journal e.g. reviews are generally more heavily cited than articles, and editorials, book reviews etc. may go uncited Normalization puts data into context is an entity doing better or worse than would be expected in a journal or category?

12 Which government institutions are doing high impact research in I/O? Top 5 U.S. government organizations by CNCI 12

13 Which academic institutions are doing high impact research in I/O? Top 5 U.S. academic organizations by CNCI 13

14 Which corporate institutions are doing high impact research in I/O? Top 5 corporate organizations by CNCI 14

15 15 Who are the Key Opinion Leaders on I/O? Top 10 Global Authors by CNCI Rank Name Affiliation Country Category Normalized Citation Impact 1 Topalian, Suzanne L. Johns Hopkins University USA Pardoll, Drew M. Johns Hopkins Oncology Center USA Daud, Adil University of California San Francisco USA Korman, Alan J. Bristol Myers Squibb USA Carvajal, Richard D. Memorial Sloan Kettering Cancer Center USA Chen, Lieping Yale University USA Taube, Janis M. Johns Hopkins University USA Brahmer, Julie R. Johns Hopkins Oncology Center USA Hwu, Wen-Jen UTMD Anderson Cancer Center USA Antonia, Scott J. H Lee Moffitt Cancer Center & Research Institute USA = average impact in field

16 16 Who are the Key Opinion Leaders on I/O? Top 10 Authors Outside the U.S. by CNCI Rank Name Affiliation Country Category Normalized Citation Impact 1 Kefford, Richard University of Sydney AUSTRALIA Perez-Gracia, Jose L. University of Navarra SPAIN Long, Georgina V. University of Sydney AUSTRALIA Robert, Caroline Gustave Roussy FRANCE Graus, Francesc IDIBAPS SPAIN Riddell, Stanley R. Technical University of Munich GERMANY Schachter, Jacob Chaim Sheba Medical Center ISRAEL Rusakiewicz, Sylvie Institut National de la Sante et de la Recherche Medicale FRANCE Mellman, Ira Roche Holding SWITZERLAND Lebbe, Celeste Pierre & Marie Curie University - Paris 6 FRANCE = average impact in field

17 What is the funding* landscape for I/O? Top 10 Global Funders by number of funded documents 17 *Data derived from the funding acknowledgments in the journal articles

18 What is the funding* landscape for I/O? CNCI of Top 10 Global Funders by number of funded documents BMS-Funded Institutions Web of Science 18 (Top 10 by output) Documents Memorial Sloan Kettering Cancer Center 52 Harvard University 41 Bristol Myers Squibb 40 Johns Hopkins University 35 VA Boston Healthcare System 34 Dana-Farber Cancer Institute 31 Johns Hopkins Oncology Center 30 H Lee Moffitt Cancer Center & Research Institute 23 UTMD Anderson Cancer Center 22 Cornell University = average impact in field *Data derived from the funding acknowledgments in the journal articles

19 What collaborations are happening in I/O? Top MSKCC Collaborations by number of co-authored documents MSKCC Collaborating organizations defined as co-authorship Ranked clockwise by # coauthored papers Displaying CNCI 19

20 What collaborations are happening in I/O? Top Johns Hopkins Oncology Center Collaborations by number of co-authored documents Johns Hopkins Oncology Center Collaborating organizations defined as co-authorship Ranked clockwise by # coauthored papers Displaying CNCI 20

21 21 What organizations are publishing hot papers on I/O? Organization Number of Hot Papers Harvard University 7 UNICANCER 7 Yale University 6 Gustave Roussy 6 VA Boston Healthcare System 6 University of California Los Angeles 5 Dana-Farber Cancer Institute 5 Memorial Sloan Kettering Cancer Center 5 University of Chicago 4 University of North Carolina Chapel Hill 4 Vanderbilt University 4 UTMD Anderson Cancer Center 4 Merck & Company 4 Hot Papers are papers published in the last two years, and receive the top 0.1% of citations in the past two months.

22 Who is funding* the Hot Papers in I/O? 22 Organization Number of Hot Papers National Institutes of Health (NIH) - USA 14 NIH National Cancer Institute (NCI) 8 Merck & Company 3 KWF Kankerbestrijding 2 European Research Council (ERC) 2 Hot Papers are papers published in the last two years, and receive the top 0.1% of citations in the past two months. *Data derived from the funding acknowledgments in the journal articles

23 23 Who is funding the next breakthrough? Which KOLs should I work with? What hot research am I missing?

24 24 HOT TOPIC SESSION Using Bibliometrics in the Library: Best Practices for Research Evaluation Tuesday, June 20 th 9:00-10:00 AM Room CC-223

25 Amy Braden, Solutions Specialist clarivate.com

26 Appendix

Web of Science Core Collection The world s most trusted

Powerful bibliographic and cited reference search

conferences covered, annually Over 80,000 scholarly books

Index Arts and Humanities Citation Index Emerging Sources

27 Web of Science Core Collection The world s most trusted citation index. Powerful bibliographic and cited reference search capabilities, together with the benefits of cited reference linking and navigation. Cover-to-cover indexing of over 18,000 journals Over 12,000 conferences covered, annually Over 80,000 scholarly books Science Citation Index Expanded Social Sciences Citation Index Arts and Humanities Citation Index Emerging Sources Citation Index Conference Proceedings Citation Index Book Citation Index Multidisciplinary International Influential Master Journal List Conferences List Book List

28 Web of Science Core Collection Search 28 The following search was used for the immuno-oncology analysis in this presentation: TOPIC = ("immuno oncol*" or (immunotherap* and (cancer or tumo$r* or neoplas* or oncol* or *oma))) Refined by: DOCUMENT TYPES: (ARTICLE OR REVIEW OR PROCEEDINGS PAPER) AND [excluding] DOCUMENT TYPES: (RETRACTED PUBLICATION )

Clinical Activity and Safety of Anti-PD-1 (BMS , MDX-1106) in Patients with Advanced Non-Small-Cell Lung Cancer

Clinical Activity and Safety of Anti-PD-1 (BMS-936558, MDX-1106) in Patients with Advanced Non-Small-Cell Lung Cancer J.R. Brahmer, 1 L. Horn, 2 S.J. Antonia, 3 D. Spigel, 4 L. Gandhi, 5 L.V. Sequist,